Arkolith/Insider Trading/SONN/Form 4

Cini John K.

Chief Scientific OfficerSonnet BioTherapeutics Holdings, Inc. (SONN) · full profile →Form 4 · filed Feb 17, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2023Disposed to issuer(D)19K——22K
Jan 7, 2023Grant(A)19K——40K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-005465) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML